FutureWorld Corp. (FWDG)
Saint Petersburg, FL, US
FutureWorld Corp., along with its affiliated entities, is primarily focused on the global identification, acquisition, development, and market introduction of various products, services, and technologies related to hemp and cannabis. The company offers an extensive range of solutions for the industrial hemp and legal medicinal marijuana sectors. These include advanced smart sensor systems, robust communication networks, and comprehensive surveillance security to optimize cultivation practices and enhance protection. They provide critical data analysis tools for "smart cultivation" and expert consultation services. Among their specialized products are personal and professional test kits for detecting tetrahydrocannabinol (THC) and Cannabidiol (CBD). They also supply pharmaceutical-grade CBD oil and URVape vaporizer pens, designed for oil vaporization across the e-cigarette, cannabis, and herbal industries. For cultivation management, FutureWorld offers CaNNaLyTiX, a dashboard controller system that integrates various computer systems within a grower's infrastructure, and CaNNaTRAK, a barcode and RFID tracking system crucial for maintaining seed-to-sale traceability of hemp and cannabis products. Security is further bolstered by SPIDer (secure perimeter intrusion detection network), which addresses the risk of theft and malicious attacks. Additional agricultural technology includes SmartSense, providing wireless security and a smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses specifically for the hemp industry. SmartNergy offers tools to analyze and optimize a cultivator's energy consumption. Their CaNNaBoX machine provides automated dispensing, requiring a card swipe to verify a medical marijuana patient's identity, age, and prescription before releasing measured product packages. FutureWorld serves a diverse customer base, reaching consumers directly through online sales and dedicated health and wellness stores. They also engage with collectives, cooperatives, and facilitate sales through affiliate and master distributors. Originally established in 2002 as FutureWorld Energy, Inc., the company changed its name to FutureWorld Corp. in June 2014 and is headquartered in Saint Petersburg, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +2,900.00% | +0.00% | +0.00% | +2,900.00% | +0.00% | +2,900.00% | -95.71% | -85.00% | -99.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-100.0% Q4'16: +1,623.0% (vs Q4'15)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+90.6% ★ Q4'16: -97,800.0% (vs Q4'15)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%— Q4'16: -64.6% (vs Q4'15)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%— Q4'16: -433.5% (vs Q4'15)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q4'16: -2.8% (vs Q4'15)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+293.9% Q4'16: -99.7% (vs Q4'15)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×0.62× Q4'16: 0.11× (vs Q4'15)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 46-4896047 | 254.73M | 9.98% | 254.73M | — | 254.73M | — | OO | NEW YORK | 2016-02-25 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Saeed Talari | Chairman of the Board & Chief Executive Officer | 180.0K | male |
| Douglass W. Wright | Co-Founder | — | male |
| Karin Rohret | Controller | — | female |
| Sam Khan | Vice President of Sales & Marketing | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FWDG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
